Sylvamo Corporation Common Stock SLVM 深 沪
交易中 07-21 11:31:00 美东时间
49.295
+0.435
+0.89%
华盛通- 最 高49.62
- 今 开49.31
- 成交量 3.11万股
- 最 低 49.035
- 昨 收 48.86
- 总市值 20.07亿
- 52周最高 96.67
- 市盈率 静 6.86
- 换手率 0.08%
- 52周最低 48.67
- 委 比 1.30%
- 总股本 4072.27万
- 历史最高 96.67
- 量 比 0.34
- 振 幅 1.20%
- 历史最低 18.675
- 每 手 1
- 风险率 12.76%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多B of A Securities Maintains Underperform on Sylvamo, Lowers Price Target to $64
B of A Securities analyst George Staphos maintains Sylvamo (NYSE:SLVM) with a Underperform and lowers the price target from $67 to $64.
07-09 23:37
Sidoti Events, LLC's Virtual June Small-Cap Conference
NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Sidoti Events, LLC, an affilia...
06-10 19:30
Sylvamo Corp Updates By-Laws and Elects Directors
Sylvamo Corp ( ($SLVM) ) has issued an update. On May 15, 2025, Sylvamo Corpora...
05-17 02:28
美股大行评级 | 潜在涨幅158.9%！蒙特利尔银行上调Disc Medicine目标价至120美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从112美元升至120美元</p> <p>• 巴克莱：维持Karyopharm Therapeutics(KPTI)"超配"评级，目标价从5美
05-14 08:48
美股大行评级 | 潜在涨幅455.56%！Medicus Pharma获D. Boral Capital升目标价至27美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1128971739548127232.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• D. Boral Capital：维持Medicus Pharma(MDCX)"买入"评级，目标价从14美元升至27美元</p> <p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从
05-13 08:50
RBC Capital Maintains Sector Perform on Sylvamo, Lowers Price Target to $61
RBC Capital analyst Matthew McKellar maintains Sylvamo (NYSE:SLVM) with a Sector Perform and lowers the price target from $70 to $61.
05-13 00:09
Sylvamo shares are trading lower following mixed Q1 results.
Sylvamo shares are trading lower following mixed Q1 results.
05-10 03:02
Sylvamo Expects Q2 FY2025 Adjusted EBITDA Of $75M-$95M
Second Quarter OutlookAdjusted EBITDA of $75 million to $95 millionCompared to the first quarter:Price and mix are expected to improve by $5 million to $10 million due to favorable mix in Latin America and North
05-09 19:06
Earnings Scheduled For May 9, 2025
Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is projected to ...
05-09 16:32
Sylvamo Q1 2025 Earnings Preview
Sylvamo (NYSE:SLVM) is scheduled to announce Q1 earnings results on Friday, May 9th, before market open. The consensus EPS Estimate is $0.69 (-35.5% Y/Y) and the consensus Revenue Estimate is $815.91M...
05-09 00:27
